Men Under Microscope – Lifestyle
Home
Sample Page
Author:
CG Oncology Inc.
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 19, 2026
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 15, 2026
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
May 11, 2026
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
May 8, 2026
CG Oncology to Present at Upcoming Investor Conferences in May
May 5, 2026